NCT02857153

Brief Summary

This will be a multicentre, randomised, controlled and prospective clinical trial. All participants provided their written informed consent to participate in a randomized trial that examined the effects of low-level MAP (60-70 mmHg) vs. high-level MAP (90-100 mmHg) in elderly patients (65 or more years of age) during noncardiothoracic surgery under general anesthesia. The investigators hypothesise high-level blood presure of the intervention for reducing the incidence of post-operative complications.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
322

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2016

Geographic Reach
1 country

7 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

July 15, 2016

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 5, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2017

Completed
Last Updated

August 16, 2016

Status Verified

August 1, 2016

Enrollment Period

1 year

First QC Date

July 15, 2016

Last Update Submit

August 15, 2016

Conditions

Keywords

MAPBlood lossPostoperative deliriumElderly patientsNoncardiothoracic surgery

Outcome Measures

Primary Outcomes (1)

  • Incidence of delirium

    Within the first 7 days after surgery

Secondary Outcomes (4)

  • Delirium duration days (Postoperative delirium defined by the confusion assessment method for the ICU (CAM-ICU))

    Within the first 7 days after surgery

  • Intra-operative blood loss

    Intra-operative

  • Intraoperative urine volume.

    Intra-operative

  • All-cause 28-day mortality.

    The investigators would observe it within the 28-day period after surgery.

Study Arms (2)

Low-level MAP

EXPERIMENTAL

According to grouping, MAP is regulated to the goal level (60-70 mmHg) during general anesthesia.

Drug: UrapidilDrug: PhenylephrineProcedure: Low-level MAP

High-level MAP

EXPERIMENTAL

According to grouping, MAP is regulated to the goal level (90-100 mmHg) during general anesthesia.

Drug: UrapidilDrug: PhenylephrineProcedure: High-level MAP

Interventions

If necessary, intravenous urapidil 0.2-0.5 mg/kg when mean arterial pressure exceeded 10 mmHg of the target value, rather than more anesthesia, may be used in situations wherein sympathetic stimulation was high; yet a sufficient amount of anesthesia was being administered and bispectral index showed an adequate depth of hypnosis. Sedation was provided by a propofol infusion targeted to a BIS number of approximately 50 during general anesthesia.

Also known as: Ebrantil
High-level MAPLow-level MAP

If necessary, intravenous phenylephrine 4-6 μg/kg when mean arterial pressure exceeded 10 mmHg of the target value, rather than more anesthesia, may be used in situations wherein sympathetic stimulation was high; yet a sufficient amount of anesthesia was being administered and bispectral index showed an adequate depth of hypnosis. Sedation was provided by a propofol infusion targeted to a BIS number of approximately 50 during general anesthesia.

Also known as: Metaoxedrin, Neosynephrine
High-level MAPLow-level MAP
Low-level MAPPROCEDURE

MAP is regulated to the goal level (60-70 mmHg) during general anesthesia.

Low-level MAP

MAP is regulated to the goal level (90-100 mmHg) during general anesthesia.

High-level MAP

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • male and females, American Society of Anesthesiologists I-II-III, 65 or more years of age, scheduled to undergo noncardiothoracic surgery with general anesthesia are enrolled.

You may not qualify if:

  • the patient suffered from Cardiovascular Disease and Metabolic Diseases, such as hypertension, cardiac disease, diabetes;
  • the patient has severe liver, kidney or blood disease;
  • the patient is accompanied severe cognitive impairment (Mini-Mental State Examination (MMSE) score \< 15);
  • preoperative history of schizophrenia, epilepsy, parkinsonism, use of cholinesterase inhibitor, or levodopa treatment;
  • use of haloperidol or other neuroleptics during or after anesthesia;
  • neurosurgery;
  • individuals unlikely to survive for \>24 hrs; previous participation in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Shenzhen People's Hospital

Shenzhen, Guangdong, 518001, China

RECRUITING

The affiliated Hospital of Guizhou Medical University

Guiyang, Guizhou, 550000, China

RECRUITING

Henan Provincial People's Hospital

Zhengzhou, Henan, 450000, China

RECRUITING

Taihe Hospital affiliated to Hubei University of Medicine

Shiyan, Hubei, 442000, China

RECRUITING

West China Hospital affiliated to Sichuan University

Chengdu, Sichuan, 610000, China

RECRUITING

Sichuan Provincial People's Hospital

Chengdu, Sichuan, 641000, China

RECRUITING

The Third Affiliated Hospital of Kunming Medical University

Kunming, Yunnan, 650000, China

RECRUITING

Related Publications (6)

  • London MJ. Intraoperative Mean Blood Pressure and Outcome: Is 80 (mmHg) the "New" 60? Anesthesiology. 2016 Jan;124(1):4-6. doi: 10.1097/ALN.0000000000000923. No abstract available.

    PMID: 26540150BACKGROUND
  • Monk TG, Bronsert MR, Henderson WG, Mangione MP, Sum-Ping ST, Bentt DR, Nguyen JD, Richman JS, Meguid RA, Hammermeister KE. Association between Intraoperative Hypotension and Hypertension and 30-day Postoperative Mortality in Noncardiac Surgery. Anesthesiology. 2015 Aug;123(2):307-19. doi: 10.1097/ALN.0000000000000756.

  • Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, Cywinski J, Thabane L, Sessler DI. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013 Sep;119(3):507-15. doi: 10.1097/ALN.0b013e3182a10e26.

  • Chang HS, Hongo K, Nakagawa H. Adverse effects of limited hypotensive anesthesia on the outcome of patients with subarachnoid hemorrhage. J Neurosurg. 2000 Jun;92(6):971-5. doi: 10.3171/jns.2000.92.6.0971.

  • Reich DL, Bennett-Guerrero E, Bodian CA, Hossain S, Winfree W, Krol M. Intraoperative tachycardia and hypertension are independently associated with adverse outcome in noncardiac surgery of long duration. Anesth Analg. 2002 Aug;95(2):273-7, table of contents. doi: 10.1097/00000539-200208000-00003.

  • Hu A, Qiu Y, Zhang P, Hu B, Yang Y, Li S, Zhao R, Zhang Z, Zhang Y, Zheng Z, Qiu C, Li F, Gong X. Comparison of the effect of high versus low mean arterial pressure levels on clinical outcomes and complications in elderly patients during non-cardiothoracic surgery under general anesthesia: study protocol for a randomized controlled trial. Trials. 2017 Nov 21;18(1):554. doi: 10.1186/s13063-017-2233-8.

MeSH Terms

Conditions

Blood Loss, SurgicalEmergence DeliriumHemorrhage

Interventions

urapidilPhenylephrine

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsIntraoperative ComplicationsDeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsSigns and SymptomsNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

EthanolaminesAmino AlcoholsAlcoholsOrganic ChemicalsAmines

Study Officials

  • Hu Anmin

    Jinan University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Shenzhen People's Hospital

Study Record Dates

First Submitted

July 15, 2016

First Posted

August 5, 2016

Study Start

July 1, 2016

Primary Completion

July 1, 2017

Study Completion

October 1, 2017

Last Updated

August 16, 2016

Record last verified: 2016-08

Locations